|
| 37590492 | Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy. | Radiat Res | 2023 |
| 38019269 | Alcohol, smoking, and risks of breast cancer recurrence and mortality among women with luminal, triple-negative, and HER2-overexpressing breast cancer. | | 2023 |
| 35347551 | Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ. | Breast Cancer Res Treat | 2022 |
| 33779721 | Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young Women. | Journal of the National Cancer Institute | 2022 |
| 35315524 | Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds. | Int J Cancer | 2022 |
| 35061141 | Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis: a nested case-control study. | Cancer Causes and Control | 2022 |
| 34845211 | Mammographic texture features associated with contralateral breast cancer in the WECARE Study. | NPJ Breast Cancer | 2021 |
| 33544892 | Race, ethnicity and risk of second primary contralateral breast cancer in the United States. | International Journal of Cancer | 2021 |
| 33762354 | Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma <i>In Situ</i>. | Cancer Res | 2021 |
| 34330103 | Receipt of Screening Mammography by Insured Women Diagnosed With Breast Cancer and Impact on Outcomes. | J Natl Compr Canc Netw | 2021 |
| 32119081 | Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer. | J Natl Cancer Inst | 2020 |
| 31409314 | Pre-diagnosis alcohol consumption and mortality risk among black women and white women with invasive breast cancer. | BMC Cancer | 2019 |
| 31560388 | Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. | JAMA Netw Open | 2019 |
| 30542984 | CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. | Cancer Causes Control | 2019 |
| 30539315 | Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma. | Cancer Causes Control | 2019 |
| 31360852 | Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ. | JNCI Cancer Spectr | 2018 |
| 28963606 | Agreement between self-reported and register-based cardiovascular events among Danish breast cancer survivors. | J Cancer Surviv | 2018 |
| 30526633 | CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. | Breast Cancer Research | 2018 |
| 29898891 | Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 29357906 | Body mass index at age 18Â years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. | Breast Cancer Res | 2018 |
| 29566728 | The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. | Breast Cancer Research | 2018 |
| 29620998 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. | Journal of Clinical Oncology | 2018 |
| 29339357 | Family History and Risk of Second Primary Breast Cancer after <i>In Situ</i> Breast Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 29254937 | Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 28086982 | Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis. | Breast Cancer Res | 2017 |
| 28503721 | Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. | Breast Cancer Res Treat | 2017 |
| 28724391 | Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. | Breast Cancer Research | 2017 |
| 28524234 | Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study. | International Journal of Cancer | 2017 |
| 28567703 | Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74Â Years. | Hormones and Cancer | 2017 |
| 28521362 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. | Journal of the National Cancer Institute | 2017 |
| 29059683 | Association analysis identifies 65 new breast cancer risk loci. | Nature | 2017 |
| 29058716 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. | Nat Genet | 2017 |
| 27551723 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. | PLoS Med | 2016 |
| 27053251 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. | Cancer Causes Control | 2016 |
| 27400983 | Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. | Breast Cancer Research | 2016 |
| 27117709 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. | Nat Commun | 2016 |
| 27700016 | Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer. | Cancer Med | 2016 |
| 24923811 | Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. | Pharmacoepidemiol Drug Saf | 2015 |
| 25924995 | Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status. | Cancer Med | 2015 |
| 25751625 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. | Nat Genet | 2015 |
| 26751177 | Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. | SpringerPlus | 2015 |
| 26138067 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. | Hum Mol Genet | 2015 |
| 26084603 | Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer. | Cancer Epidemiology Biomarkers and Prevention | 2015 |
| 26296642 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. | J Natl Cancer Inst | 2015 |
| 26150446 | Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers. | Journal of Clinical Oncology | 2015 |
| 25192706 | Bra wearing not associated with breast cancer risk: a population-based case-control study. | Cancer Epidemiology Biomarkers and Prevention | 2014 |
| 25359301 | The risk of breast cancer associated with specific patterns of migraine history. | Cancer Causes Control | 2014 |
| 25301086 | Metabolic syndrome and outcomes following early-stage breast cancer. | Breast Cancer Res Treat | 2014 |
| 24500704 | Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years. | Cancer | 2014 |
| 24493630 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. | Cancer Epidemiol Biomarkers Prev | 2014 |